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ABSTRACT  We have shown that glucocorticoids  reversibly change the growth  control  of rat 
C6 glioma cells from a transformed to a normal pattern. Here we report that the glucocorticoid 
hormone  hydrocortisone  (Hy) modulates  structure  and  function  of cell  surface and  cyto- 
skeleton.  The  hormone  is  shown  to cause: (a)  increased flattening  and adhesion to  solid 
substrates and to fibrin  layers, (b) inhibition of the cell shape change triggered by catechol- 
amines and  cAMP, (c)  extensive  fibronectin  deposition  on  normally  fibronectinless  cells' 
surface, and (d) microtubule  rearrangement. Comparison of Hy-hypersensitive and Hy-resist- 
ant variants showed that microtubule  rearrangements correlate with the growth control change 
induced by Hy, whereas fibronectin  deposition does not. 
The pattern of proliferation control of C6 rat glioma cells (l) 
changes under the action of the glucocorticoid hormone hy- 
drocortisone (Hy). This hormone restores serum and anchor- 
age dependence to the fully transformed and malignant cells 
and interferes with cell cycle control by affecting cell travers- 
ing rate exclusively at the G~ phase of the cell cycle (2). Hy 
also renders C6 cells dependent on high external Ca  2+ concen- 
trations for growth (3) and sensitive to a G~ block by micro- 
tubule-disrupting agents (4, 5). 
We show here that Hy induces cell flattening, increases cell 
adhesion to plastic surfaces and to fibrin layer and inhibits 
the  characteristic  cell  shape  change  induced  by  catechol- 
amines and cAMP in glial cells. The basis for this change was 
examined by analyzing the effects of the hormone on cell 
surface and cytoskeleton of Hy-hypersensitive and Hy-resist- 
ant C6 variants. We show that the mechanisms by which Hy 
confers a new growth pattern to C6 glial cells probably involve 
alterations of cytoskeletal architecture. 
MATERIALS AND  METHODS 
Cells and Culture Conditions:  Rat C6 glioma cell line (CCL 101) 
was originally obtained  from American  Type  Culture  Collection  (Rockville, 
MD). Isolation and characterization  of C6 variants are described in the accom- 
panying paper (2) and in reference 6. For culture conditions, see accompanying 
paper (2). 
Immunofluorescence  Staining:  Cells were  grown  on  0.81-cm 2 
coverslips to different cell densities. For surface fibronectin staining, coverslip 
cultures  were rinsed  in  phosphate-buffered  saline (PBS) for 5 min in  3.7% 
formaldehyde-PBS and washed thoroughly before adding 12/zl of l / 100 dilution 
rabbit  anti-bovine  cold  insoluble  globulin  (CIG)  whole  serum  (generously 
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provided by Dr. D. Rilkin  [New York University] and Dr. R. Hynes [Massa- 
chusetts  Institute  of Technology]).  After  incubating  for 20  min at  37"C in 
humidified  atmosphere,  coverslips were extensively washed,  12 ul of a  1/25 
dilution  FITC-conjugated  goat  anti-rabbit  IgG (Miles,  Yeda  Ltd.,  Rehovot, 
Israel) was added,  and incubated  for another 20 min at 37"C. Upon several 
washings in PBS, coverslips were rinsed once  in distilled water, mounted in 
90%  glycerin-10%  carbonate  buffer,  pH  9.3, and  sealed with  nail  polish. 
Controls consisting of omitting the first antiserum  or substituting  rabbit anti- 
bovine CIG by nonimmune rabbit serum were routinely included in all exper- 
iments and were consistently negative under the above described conditions. 
For cytoskeleton staining, coverslip cultures were rapidly washed in Ca2+-free 
PBS at room temperature  before fixing in methanol  for 6 rain at -15*C,  as 
suggested in  reference  7.  The  methanol  treatment  was  adopted  as  having 
significantly better results, after testing several other fixation and permeabili- 
zation procedures. After rehydration  in Ca  2÷ free PBS, coverslips were covered 
with 12 ul of a 1/25 dilution rabbit-antitubulin  antiserum (generously provided 
by Dr. D. Rifkin, New York University; and Drs. E. Meier and O. L. Jorgensen 
(University of Copenhagen, Denmark); see reference 8) or antiactin  antiserum 
(generously provided by Dr.  K. Burridge, Cold Spring Harbor Laboratories). 
In cases where cells were negative for anti-actin  staining, lower dilutions (l/10 
or 1/5) were also used. All reactions were run with internal  positive controls 
(usually Swiss mouse 3T3 fibroblasts) and negative controls (as described for 
fibronectin  staining).  After  incubation  for  30  min  at  37"C with  the  first 
antiserum, coverslips were washed, FITC-conjugated goat anti-rabbit serum (l/ 
25 dilution)  was added,  and the preparation  was incubated  and mounted as 
described for fibronectin staining. 
All coverslips were examined under a Zeiss Universal microscope equipped 
with 200 W HBO lamp and epifluorescence. Photomicrographs  were taken on 
Kodak Tri-X 400 ASA film and for the same exposure time (usually 30 s for 
fibronectin and 45 s for cytoskeleton). All films were developed with Kodak D- 
76 developer for 8 min at 22"C. 
Mutagenization of ST1 Cells with N-Methyi-Nitro-N-Nitro- 
soguanidine:  4.5 x  106 exponentially growing STI cells were treated with 
several different concentrations  of freshly made N-methyl-nitro-N-nitrosoguan- 
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was observed for cultures treated with 1.2 mg/ml MNNG for 3.5 h. These 
cultures were allowed to grow for 8 d to recover from mutagenesis.  Mutation 
rate, assayed by the frequency of thioguanine (TG) resistance,  was 2 x  10  -5, 
estimated from cultures plated at  105 cells per 60-mm dish; no TG-resistant 
colonies were seen in nonmutagenized cultures even at  104 cells per 60-ram 
dish. Morphological variants were frequent among colonies originated from 
mutagenized cultures. The  mutagenized population was  screened for  Hy- 
resistant variants in agarose suspension  cultures, giving  negative  results. 
Plasminogen Activator Assay:  We prepared fibrin  plates by adding 
0.1 ml of a  1 mg/ml bovine thrombin solution to each petri dish (Nunc, 35 
mm diameter), followed by addition of 2 ml of 0.5% fibrinogen solution in 
PBS (bovine fibrinogen I; ICN Nutritional Biochemicals, Cleveland, OH), 
rapidly mixing, and allowing  to stand for gelification.  All solutions were filter 
sterilized in 0.22-um GS type Millipore filter. Thrombin (33% purity was 
prepared and generously  provided by Dr. J. R. Gigiio [Faculdade  de Medicina 
de Ribeirao Preto, Universidade  de Sao Paulo]).  Cells  were plated directly  onto 
this fibrin layer at different cell densities, and lysis zones or growth (in case 
cells did not produce plasminogen  activator)  were monitored. 
Fibrinolytic  activity  was quantitated using  the method described  by Unkeless 
et al. (9). Radioiodinated ~25I-fibrinogen  coated Linbro 24-well plates were 
activated to fibrin immediately  before  use by incubation with 0.5 ml/well 2.5% 
FCS-DME for 1 h at 37"C. Cells  were either plated directly onto the ~251-fibrin 
coated wells or seeded in regular plates, allowed to reach exponential phase 
(usually  48 h), washed, and incubated with serum-free DME for 6 h. Radioac- 
tivity released to the supernatant by cells or by medium conditioned by the 
cells in serum-free  medium was measured by applying  aliquots to paper filters, 
drying, and counting in a  Beckman liquid scintillation counter (Beckman 
Instruments, Inc., Palo Alto, CA). Total radioactivity  per well  was determined 
by incubation with 0.5 ml/well 0.1% trypsin solution. Results were expressed 
as percent of total radioactivity released as a function of time. Less than 5% 
radioactivity  was released  in controls incubated with unconditioned  serum-free 
medium or fresh 5% FCS-DME. 
RESULTS 
Alterations of Cell Morphology, Adhesion, and 
Cytoskeleton Functioning Caused by Hy 
Hy causes flattening of C6 glioma cells anchored to a  solid 
substrate,  leading to  organized,  nonoverlapping monolayers 
(Fig.  1, A and B). Also, upon trypsinization, hormone-treated 
cells take longer to detach from the substrate (3 and 15 min, 
respectively). These alterations of adhesion and morphology 
suggested that the hormone might be inducing modifications 
of  cell  surface  composition  and/or  cytoskeleton.  Another 
indication came from plating STI variant, at low cell density, 
on top of a  fibrin layer (Fig. 2A). Single cells grew into three- 
dimensional colonies, resembling growth  in agarose  suspen- 
sion.  Addition  of  Hy  to  such  cultures  caused  the  cells  to 
acquire a  stretched and elongated shape and to adhere firmly 
to fibrin; growth of these fibrin-attached cells was completely 
arrested  (Fig.  2 B).  Hy  renders the  growth  of ST I  cells an- 
chorage dependent (2); however, it seems that fibrin does not 
provide an adequate  substrate  so as  to  allow growth  in the 
presence of Hy, 
Our experiments were  made  possible because  these  glial 
cells do not secrete plasminogen activator irrespective of the 
presence  or  absence  of Hy.  That  is  not  the  case  with  the 
majority of transformed cells (9-1 1).  When  3T6  fibroblasts 
were plated onto fibrin layers, the cells digested the fibrin and 
grew  on  the  bottom  of the  dish.  The  lack  of plasminogen 
activator activity in ST1  cells was also confirmed by the  ~25I 
fibrin digestion assay (carried  out as described  in  Materials 
and Methods).  The  same assay applied to  SV3T3  and  3T6 
fibroblasts was strongly positive. 
Cell  flattening and  increased  adhesion  to  fibrin are  late 
effects of Hy,  taking up to  24 h  to  be clearly observed.  An 
early effect of the hormone can also be shown to occur and 
to be dependent on cytoskeleton alterations, namely, inhibi- 
tion of the morphological change caused by catecholamines 
and cAMP.  Hydrocortisone inhibits the modification in cell 
shape brought about by cAMP in STI cells (Fig. 3A). This is 
an early hormonal effect that can be observed with the first 2 
h  of hormone treatment (Fig. 3 B). Addition of theophylline 
(a phosphodiesterase inhibitor) along with cAMP or dibutyryl- 
cAMP did not alter these results. This hydrocortisone action 
seems to  depend on protein synthesis since it is blocked by 
cycloheximide  (Fig.  3B).  Hy  also  inhibited  the  cell  shape 
modification induced by isoproterenol (not shown). 
Hydrocortisone Induction of Fibronectin 
Deposition on C6 Cell's Surface 
A  highly conspicuous alteration of cell surface induced by 
Hy in ST 1 cells is the deposition of fibronectin (FN) on the 
cell surface. This hormonal effect was demonstrated by indi- 
rect  immunofluorescence using rabbit-anti-bovine CIG.  No 
FN was found on the surface of STI  cells (Fig. 4A). Physio- 
logical concentrations of Hy (250 ng/ml) caused progressive 
accumulation of an extensive FN meshwork (Fig. 4 B). This 
is a  relatively late hormonal effect, i.e., a  meshwork through- 
out the whole culture could only be seen after 24 h of hormone 
treatment.  It  is  important to  note  that  FN  deposition  also 
FIGURE  1  Morphological alterations caused in ST1 cells by Hy (flattening) and cAMP (rounding up). (A) Control, untreated cells. 
(B) Treated with 250 ng/ml Hy for 24 h. (C) Treated with 1 mM cAMP for 30 min. Bar, 30 #m. 
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serum-free medium (not shown). 
Induction  of FN  deposition  probably contributes  to  the 
increased flattening and spreading to solid substrate and adhe- 
sion  to  fibrin.  However,  we  have evidence  indicating  that 
adhesion and spreading of C6 cells on solid substrate depend 
on  components other than  FN.  Plating  of C6  cells  (several 
variants) onto dishes coated with bovine CIG, in serum-free 
medium, did not result in cell spreading, irrespective of the 
presence of Hy in the hormonal supplement. Well-spread cells 
were obtained only when dishes were precoated with fetal calf 
serum. Serum components that are not displaceable by several 
washings with  PBS  are  necessary for optimal cell adhesion 
and spreading. 
FIGURE  2  Effect  of  Hy  on  growth of  ST1  cells on  top  of a  fibrin 
layer. 103 cells were seeded on 35-mm fibrin coated dishes in 1 ml 
of  15%  FCS-DME,  in the  absence (A) or  presence (B) of  Hy  (250 
ng/ml). Refeeding, by gentle aspiration of the old medium, every 3 
d. Micrographs taken at 9 d after seeding. Bar, 30 #m. 
Also, FN deposition is neither necessary nor sufficient for 
the  modification  in  growth  control  induced  by  Hy.  The 
evidence  for  this  comes  from  analysis  of Hy-resistant C6 
variants and  of ST I  variant clones  isolated  from MNNG- 
mutagenized cultures. 
We  examined  the  effect of Hy on  FN  deposition  in  C6 
variants. The results of Fig.  5 show that:  (a) occasional FN 
fibers were found in some of the variant clones in the absence 
of  any hormone treatment; and (b) treatment with Hy resulted 
in extensive deposition of FN in all clones under conditions 
responsive to Hy (3D and PI ~) or Hy-resistant (P5 and P7) in 
a dense meshwork of short (P5 and PT) or long (Pit and 3D) 
fibers.  These results indicated that the induction of FN dep- 
osition by Hy was not sufficient to allow alterations of cell 
growth control. 
Clones of different morphological types were also isolated 
from ST1  cells  mutagenized with  MNNG  (as described  in 
Materials and Methods).  In one of these clones (E5-C2),  Hy 
treatment  rapidly  and  effectively caused  both  the  growth 
control  change  and  inhibition  of the  change  in  cell  shape 
caused by cAMP; however, no FN was detected up to 72 h of 
hormone treatment. FN could clearly be seen by 120 h of Hy 
treatment but never reached the levels observed with parental 
(ST1) cells.  These results suggest  that FN deposition is not 
necessary for Hy to change growth control in ST1  cells. 
Microtubules' Rearrangements Caused by Hy in 
Hormone-sensitive Cells 
We probed the effect of Hy treatment on C6 cells' cytoskel- 
eton by indirect immunofluorescence using antitubulin  and 
antiactin antisera. 
ST1  cells stained with antitubulin presented a  "dispersed" 
pattern in which cytoplasmic fluorescence is seen but clearly 
a defined microtubule network is seldom displayed (Fig. 6A). 
Hy-treated ST1 cells presented a "network" pattern, i.e., 100% 
of the  cells showed  a  clearly defined  microtubule  network 
distributing  radially  from a  bright  perinuclear  region  (Fig. 
6 B). This network (as well as that displayed by normal 3T3 
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FIGURE  3  ST1  cells rounding-up caused by cAMP: effects of Hy and cycloheximide. (A) Cyclic nucleotide dose-response curve. 
Cells were treated with Hy (250 ng/ml) for 24 h before being submitted to the indicated concentrations of cAMP (0) and cAMP 
+1  mM theophylline (o). 60 min after cyclic nucleotides addition, cultures were scored for rounded-up cells. Hormone-untreated 
cultures (same density as Hy-treated ones) were also subjected to cAMP (O), dibutyryl cAMP (ix), and cGMP (13). (B) Hy treatment 
as a function of time. 250 ng/ml Hy alone (O) or with 1.5 mM cycloheximide (ID)  were added to the culture medium at zero time. 
At the indicated times, cultures were submitted to 1 mM cAMP and, 60 min later, scored for rounded-up cells. 
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staining for fibronectin: effect of 
Hy treatment on ST1  cells. Cells 
were cultured in the absence (A 
and D) or presence (B and C) of 
Hy (250 ng/ml) for 72 h prior to 
staining  for  fibronectin  as  de- 
scribed  in  Materials and  Meth- 
ods.  A,  B,  and  C:  ST1  cells.  D: 
Swiss 3T3 fibroblasts. C: control, 
nonimmune rabbit serum. A, B, 
and  D:  anti-ClG  rabbit  serum. 
Bar, 6 ~.m. 
fibroblasts used as controls) was totally disrupted by colchicine 
treatment (0.4 ug/ml for 1 h). Hy treatment induced the same 
change in  microtubule patterns in  clones P2 and  P~  which 
are  Hy-resistant  in  suspension  but  Hy-sensitive when  an- 
chored to solid substrates. 
The same fluorescence pattern shown in Fig.  6A was also 
seen for cells kept in 0.2% FCS-medium or 5% FCS-medium 
plus 2.5  mg/ml polybrene for 24  h.  This polycation causes 
extensive cell  flattening without interfering with growth rate 
(13).  Therefore reduced growth rate and flattening were not 
effective to  lead to the  network  pattern observed upon  Hy 
treatment. 
Antitubulin  staining of the Hy-resistant variant, clone PT, 
presented the "dispersed" fluorescence pattern irrespective of 
Hy treatment (Fig.  6,  C  and D).  The anchorage-dependent 
variant clone 3D, on the other hand, displayed the "network" 
pattern even in the absence of Hy. These results show a strong 
correlation  between  microtubules'  rearrangement  and  the 
growth control change induced by Hy. 
Staining of microfilaments with antiactin was carried out 
with C6 and its variant clones. No actin cables were ever found 
in  clones STI,  P2,  Ps,  PT,  or P~  despite the  use of culture 
conditions  that  optimize  visualization  of these  fibers  (low 
serum medium, coated surfaces, etc.).  Under Hy treatment, 
no cables were found in hormone-sensitive or -resistant var- 
iants.  In  fibroblasts,  the  fibronectin  network  on  the  outer 
surface is found to correlate with actin cables underneath the 
membrane (14,  15). In the glial cells studied, the fibronectin 
meshwork induced by Hy was not accompanied by the ap- 
pearance of actin cables. The only variant in which character- 
istic  cables were found was the  anchorage-dependent clone 
3D, irrespective of Hy treatment (not shown). 
DISCUSSION 
Our results show that glucocorticoid hormone Hy is capable 
of modulating surface composition and cytoskeleton organi- 
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zation  and  functioning  of C6  glioma cells.  Comparison  of 
several C6 growth variants show that only the effects of Hy 
on cytoskeletal elements correlate with the change in growth 
control induced by the hormone in these cells. 
The effects of Hy on cell  flattening and adhesion to solid 
substrates and  to  fibrin (Figs.  1 and  2)  led  us  to  consider 
possible  hormonal  effects  on  cell  surface,  membrane  and 
cytoskeleton underlying the growth control change. 
A  striking  effect of Hy on  cell  surface composition  was 
detected as an extensive fibronectin deposition (Fig. 4). In the 
case of the Hy-hypersensitive variant ST l, no fibronectin was 
detected in the absence of the hormone including cells that 
had been permeabilized with detergents or organic solvents. 
Upon Hy treatment, fibronectin could be found both under- 
lying isolated cells in sparse cultures and as a dense meshwork 
in confluent cultures. Glucocorticoids have been reported to 
cause modifications on the cell surface of hepatoma cells (16). 
In primary cultures of rat mammary epithelial cells, classical 
targets for glucocorticoids, Hy has been shown to stimulate 
growth by increasing type IV collagen content  in  the extra- 
cellular matrix (17). Glucocorticoids have also been reported 
to induce  fibronectin deposition  on  human fibroblasts (18) 
and rat hepatocytes (19).  Most likely,  fibronectin is contrib- 
uting to glial cells' flattening and increased adhesion.  How- 
ever, flattening and increased adhesion per se do not seem to 
be sufficient to change the cell growth pattern, for the follow- 
ing reasons: (a) analysis of several C6 variants (Fig. 5) indicates 
that fibronectin deposition is neither necessary nor sufficient 
for the change in growth control induced by Hy; (b) elsewhere 
we reported (13)  that polycations (polylysine and polybrene) 
cause flattening and increased adhesion of ST1  cells to solid 
substrates but do not interfere with the mode of cell prolifer- 
ation.  However, when  polycations are applied to  cells that 
have been pretreated with  Hy,  not  only are  flattening and 
adhesion enhanced, but growth is completely blocked. There- 
fore, depending on Hy treatment, the cells' interaction with FIGURE  5  Immunofluorescence staining for fibronectin: effects of Hy treatment on C6 cell variants. Untreated (A, B, C, D and E) 
and Hy-treated (250 pg/ml, 72  h) (F, G, H, I, and J) cultures were stained for fibronectin, as described in Materials and Methods. 
Clone 3D: E and F. Clone P2: B and G. Clone Ps: C and H. Clone PT: D and I; Clone Pl1: E and J. Bar,  12 pm. 
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cence  staining  for  tubulin: 
effect  of  Hy  treatment. 
Clones ST1  (A and  B).  P7 (C 
and D) and 3D (E and F) were 
cultured in  the absence  (A, 
C, and E) or presence (B, D, 
and F) of Hy (250 ng/ml for 
48 h) before staining for tub- 
ulin as described in Materials 
and Methods. Bar, 6 #m. 
the same component of the extracellular milieu (polycations) 
can lead to cell proliferation block or not. This suggests that 
alterations other than those of cell surface composition are 
caused by Hy treatment of C6 cells. 
Others have found evidence suggesting that fibronectin is 
not directly related to growth control mechanisms (20, 21). 
As described  by  others  (12),  catecholamines  and  cAMP 
cause a cell shape change in C6 cells (Fig.  1 C). Hy inhibited 
this morphological change via a process that is dependent on 
RNA and protein synthesis (Fig. 3). This cell shape change is 
dependent on microtubules' functioning as indicated by col- 
chicine-  and  nocodazole-blocking effects.  We  hypothesized 
that  Hy  inhibits  the  cAMP-induced  cell  shape  change  by 
promoting alterations on microtubule organization via tran- 
scription regulation. In favor of this idea is the change in the 
distribution of concanavalin A (Con A) receptors caused by 
Hy treatment in ST1  cells (J. Garrido, M. C. S. Armelin, and 
H.  A.  Armelin,  unpublished  results).  Through  the  Con  A- 
peroxidase technique  (22)  we observed that the distribution 
of Con A  receptors changes from a  discontinuous and clus- 
tered pattern (characteristic of transformed and mitotic cells) 
to an  evenly distributed  one (characteristic of normal cells 
[23,  24]).  The hormone treatment also prevents the intense 
endocytosis observed as abundant peroxidase-positive vesicles 
in  the  cytoplasm.  These  observations suggest  that  Hy  can 
affect the  role  that  cytoskeletal  elements  play  in  mobility 
control of membrane receptors in ST 1 cells. 
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A direct examination of microtubule organization by indi- 
rect  immunofluorescence revealed  two  distinct  patterns  in 
Hy-sensitive clones  which  we classified  as  "dispersed" and 
"network" for control and Hy-treated cells, respectively. That 
the "network" pattern induced by Hy was not secondary to 
cell  flattening was suggested by the fact that polycations do 
not  change the  "dispersed" pattern  presented  by hormone- 
untreated cells, even though extensive cell flattening is caused. 
Osborn  and  Weber (7)  have stressed that  the  diffuse cyto- 
plasmic  fluorescence  displayed  by  transformed  fibroblasts 
should not be taken to mean that these cells lack well-formed 
microtubules; in fact, microtubule fibrils could be seen in all 
preparations  of Hy-untreated  cells.  The  fact  that  the  Hy- 
resistant variant P7 displays a "dispersed" microtubules distri- 
bution irrespective of hormone treatment (Fig.  6,  C and D) 
suggests that rearrangements in microtubule organization are 
part of the mechanism(s) by which Hy changes growth control 
in these cells. Further support comes from experiments show- 
ing that Hy renders the ST1  variant susceptible to a Gn phase 
block by  colchicine  or  nocodazole  (microtubule-disrupting 
agents) ~4 h before S phase (4, 5). Thus, Hy treatment makes 
microtubule integrity necessary for GI phase traversing. This 
role  for  microtubules  has  been  suggested  before  (25-30). 
However, the effects of microtubule disrupters on GI phase 
cells seem to be complex (31-33) and have yet to be under- 
stood. 
A  correlation  between  microtubules'  rearrangement  and the growth control change induced by Hy was shown to exist 
in cultures grown attached  to solid substrates.  The fact that 
clones  P2 and Pt~  are sensitive  to Hy in  solid substrate  but 
resistant in agarose suspension does not necessarily imply that 
the growth inhibition caused by this hormone in suspension 
is independent of cytoskeletal rearrangements. Technical lim- 
itations have not allowed us to probe into the effects of Hy in 
suspension  cultures  by  immunofluorescence.  Other  ap- 
proaches  are  obviously  needed  to  clarify  the  role  of cyto- 
skeleton in the growth control change induced by Hy. 
Clone  3D  was  the  only  anchorage-dependent  C6  variant 
found  and  also  the  only  one that  failed  to  round  up  upon 
treatment  with  catecholamines  and  cAMP.  Its cytoskeleton 
was also exceptional, since actin cables and organized micro- 
tubule networks were displayed by these cells in the absence 
of any  hormone treatment.  This  cytoskeleton  organization, 
so different from that of most C6 cells,  may, in fact, explain 
why 3D cells failed to present the morphological response to 
catecholamines and cAMP. As in normal versus transformed 
fibroblasts  (34),  the  inability  of 3D cells to grow in  agarose 
suspension correlated with more the easily discernible micro- 
tubule network and the presence of actin cables. 
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